Foghorn Therapeutics Inc. (FHTX) Total liabilities 2020–2025
Foghorn Therapeutics Inc. (FHTX) total liabilities at each fiscal year-end, per SEC filings.
$306.6MFY2025 · since FY2020: $109.4M → $306.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $306.6M | -7.0% |
| FY2024 | $329.5M | -9.3% |
| FY2023 | $363.1M | -10.3% |
| FY2022 | $404.8M | -4.3% |
| FY2021 | $422.9M | +286.5% |
| FY2020 | $109.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice